Performance of molecular methods for identification of unusual subtypes of hepatitis C virus genotype 2
Abstract
Introduction: Hepatitis C virus (HCV) displays high genetic variability, with seven genotypes and numerous subtypes. The determination of the viral type has been essential for the selection and timing of antiviral treatment. In Venezuela, HCV genotype 2 is relatively diverse, being particularly prevalent subtype 2j.
Objective: To evaluate the performance of methodologies for genotyping HCV, particularly for identification of subtype 2j.
Materials and methods: HCV genotype and subtype were determined by reverse hybridization technique (LiPA) and sequencing of the HCV 5’UTR and NS5B regions.
Results: A total of 65 samples from HCV-infected patients were analyzed. PCR amplifications of the 5’UTR region exhibited the highest sensitivity (100% vs 91% for LiPA and 77% for NS5B). Genotype determination, taking as reference test NS5B, showed 100% concordance with the other methods, and 67% and 59% for subtypes with 5´NC and LiPA, respectively. NS5B sequencing allowed the identification of subtypes 2j and 2s, which were not detected by the other methods. A specific LiPA pattern was not
observed for HCV subtype 2j.
Conclusion: Although being the methodology with lowest sensitivity for amplification of HCV RNA, sequencing NS5B region remains a powerful tool for correct discrimination of the different HCV subtypes, which is of epidemiological relevance.
Downloads
References
Lanini S, Easterbrook PJ, Zumla A, Ippolito G. Hepatitis C: Global epidemiology and strategies for control. Clin Microbiol Infect. 2016;22:833-8. https://doi.org/10.1016/j.cmi.2016.07.035
Simmonds P. Genetic diversity and evolution of hepatitis C virus - 15 years on. J Gen Virol. 2004;85:3173-88. https://doi.org/10.1099/vir.0.80401-0
Hnatyszyn HJ. Chronic hepatitis C and genotyping: The clinical significance of determining HCV genotypes. Antivir Ther. 2005;10:1-11.
Tellinghuisen TL, Evans MJ, von Hahn T, You S, Rice CM. Studying hepatitis C virus: Making the best of a bad virus. J Virol. 2007;81:8853-67. https://doi.org/10.1128/JVI.00753-07
Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource. Hepatology. 2014;59:318-27. https://doi.org/10.1002/hep.26744
Timm J, Roggendorf M. Sequence diversity of hepatitis C virus: Implications for immune control and therapy. World J Gastroenterol. 2007;13:4808-17. https://doi.org/10.3748/wjg.v13.i36.4808
Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61:S45-57.
https://doi.org/10.1016/j.jhep.2014.07.027
Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study. Lancet Gastroenterol Hepatol. 2017;2:161-76. https://doi.org/10.1016/S2468-1253(16)30181-30189
Alvarado-Mora MV, Pinho JR. Epidemiological update of hepatitis B, C and Delta in Latin America. Antivir Ther. 2013;18:429-33. https://doi.org/10.3851/IMP2595
Sulbarán MZ, Di Lello FA, Sulbarán Y, Cosson C, Loureiro CL, Rangel HR, et al. Genetic history of hepatitis C virus in Venezuela: High diversity and long time of evolution of HCV genotype 2. PLoS One. 2010;5:e14315. https://doi.org/10.1371/journal.pone.0014315
Cristina J. Genetic diversity and evolution of hepatitis C virus in the Latin American region. J Clin Virol. 2005;34(Suppl.2):S1-7. https://doi.org/10.1016/S1386-6532(05)00393-8
Cuypers L, Ceccherini-Silberstein F, van Laethem K, Li G, Vandamme AM, Rockstroh JK. Impact of HCV genotype on treatment regimens and drug resistance: A snapshot in time. Rev Med Virol. 2016;26:408-34. https://doi.org/10.1002/rmv.1895
Asselah T, Boyer N, Saadoun D, Martinot-Peignoux M, Marcellin P. Direct-acting antivirals for the treatment of hepatitis C virus infection: Optimizing current IFNfree treatment and future perspectives. Liver Int. 2016;36 (Suppl.1):47-57. https://doi.org/ 10.1111/liv.13027
Jiménez-Pérez M, González-Grande R, España Contreras P, Pinazo Martínez I, de la Cruz Lombardo J, Olmedo Martín R. Treatment of chronic hepatitis C with direct-acting antivirals: The role of resistance. World J Gastroenterol. 2016;22:6573-81. https://doi.org/10.3748/wjg.v22.i29.6573
Foster GR, Afdhal N, Roberts SK, Brau N, Gane EJ, Pianko S. Sofosbuvir and Velpatasvir for HCV genotype 2 and 3 infection. N Engl J Med. 2015;373:2608-17. https://doi.org/10.1056/NEJMoa1512612
Welzel TM, Bhardwaj N, Hedskog C, Chodavarapu K, Camus G, McNally J, et al. Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses. J Hepatol. 2017;67:224-36. https://doi.org/10.1016/j.jhep.2017.03.014
Verbeeck J, Stanley MJ, Shieh J, Celis L, Huyck E, Wollants E, et al. Evaluation of Versant hepatitis C virus genotype assay (LiPA) 2.0. J Clin Microbiol. 2008;46:1901-6. https://doi.org/10.1128/JCM.02390-07
Viera AJ, Garrett JM. Understanding interobserver agreement: The kappa statistic. Fam Med. 2005;37:360-3.
Laperche S, Lunel F, Izopet J, Alain S, Dény P, Duverlie G, et al. Comparison of hepatitis C virus NS5B and 5’ noncoding gene sequencing methods in a multicenter study. J Clin Microbiol. 2005;43:733-9. https://doi.org/10.1128/JCM.43.2.733-739.2005
Scott JD, Gretch DR. Molecular diagnostics of hepatitis C virus infection: A systematic review. JAMA. 2007;297:724-32. https://doi.org/10.1001/jama.297.7.724
Baclig MO, Chan VF, Ramos JD, Gopez-Cervantes J, Natividad FF. Correlation of the 5’untranslated region (5’UTR) and non-structural 5B (NS5B) nucleotide sequences in hepatitis C virus subtyping. Int J Mol Epidemiol Genet. 2010;1:236-44.
Martró E, González V, Buckton AJ, Saludes V, Fernández G, Matas L, et al. Evaluation of a new assay in comparison with reverse hybridization and sequencing methods for hepatitis C virus genotyping targeting both 5’ noncoding and nonstructural 5b genomic regions. J Clin Microbiol. 2008;46:192-7. https://doi.org/10.1128/JCM.01623-07
Cai Q, Zhao Z, Liu Y, Shao X, Gao Z. Comparison of three different HCV genotyping methods: Core, NS5B sequence analysis and line probe assay. Int J Mol Med. 2013;31:347-52. https://doi.org/10.3892/ijmm.2012.1209
Margall N, March F, Español M, Torras X, Gallego A, Coll P. Two unusual hepatitis C virus subtypes, 2j and 2q, in Spain: Identification by nested-PCR and sequencing of a NS5B region. J Virol Methods. 2015;223:105-8. https://doi.org/10.1016/j.jviromet.2015.07.022
del Pino N, Oubiña JR, Rodríguez-Frías F, Esteban JI, Buti M, Otero T, et al. Molecular epidemiology and putative origin of hepatitis C virus in random volunteers from Argentina. World J Gastroenterol. 2013;19:5813-27. https://doi.org/10.3748/wjg.v19.i35.5813
Sulbarán MZ, Montaño L, Sulbarán Y, Loureiro CL, Flores CR, Farías Y, et al. Caracterización molecular del virus de la hepatitis C en pacientes remitidos al Laboratorio Regional de Salud Pública del Hospital Universitario “Antonio Patricio de Alcalá”, Cumaná, Venezuela. Invest Clin. 2016:57:13-24.
Jaspe RC, Sulbarán YF, Loureiro CL, Martínez N, Devesa M, Rodríguez Y et al. Genetic diversity of hepatitis B virus and hepatitis C virus in human immunodeficiency virus type 1-co-infected patients from Venezuela. J Med Microbiol. 2014:63:1099-104. https://doi.org/10.1099/jmm.0.067496-0
Chevaliez S, Bouvier-Alias M, Brillet R, Pawlotsky JM. Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice. PLoS One. 2009;4:1-9. https://doi.org/10.1371/journal.pone.0008209
Le Guillou-Guillemette H, Vallet S, Gaudy-Graffin C, Payan C, Pivert A, Goudeau A, et al. Genetic diversity of the hepatitis C virus: Impact and issues in the antiviral therapy. World J Gastroenterol. 2007;13:2426. https://doi.org/10.3748/wjg.v13.i17.2416
Some similar items:
- Ana María Perilla, Camilo González, Sandra Liliana Valderrama, Natasha Vanegas, Bibiana Chavarro, Luis Carlos Triana, José Roberto Támara, Carlos Arturo Álvarez, Necrotizing pneumonia by community-acquired, methicillin-resistant Staphylococcus aureus in Colombia , Biomedica: Vol. 29 No. 4 (2009)
- Paúl Andrés Gómez-Sandoval, Gustavo Pradilla, Re: Badillo R, Mantilla JC, Pradilla G. Encefalitis rábica humana por mordedura de murciélago en un área urbana de Colombia. Biomédica. 2009;29(3):191-203. , Biomedica: Vol. 30 No. 1 (2010)
- Alberto Morales, Letters to the editor , Biomedica: Vol. 30 No. 2 (2010)
- María del Pilar Chaves, Julián Alfredo Fernández, Isabel Ospina, Myriam Consuelo López, Ligia Moncada, Patricia Reyes, Giardia duodenalis prevalence and associated risk factors in preschool and school-age children of rural Colombia , Biomedica: Vol. 27 No. 3 (2007)
- Julián Alfredo Fernández, Alvaro Javier Idrovo, Carlos Andrés Castañeda, Vanesa Giraldo-Gärtner, Juan Gabriel Piñeros, Determinantes sociales de la malaria… ¿Aportes de la Medicina Social Latinoamericana? , Biomedica: Vol. 30 No. 3 (2010)
- Adalberto Campo-Arias, Usos del coeficiente de alfa de Cronbach , Biomedica: Vol. 26 No. 4 (2006)
- Lucía Carolina Leal-Esteban, Jessica Lineth Rojas, Andrea Lizeth Jaimes, Juan David Montoya, Nilton Edu Montoya, Lily Leiva, Claudia Milena Trujillo-Vargas, An immunoenzymatic test for IgG antibody levels against 10 serotypes of Streptococcus pneumoniae , Biomedica: Vol. 32 No. 1 (2012)
- Roosevelt Fajardo, José Ignacio Valenzuela, Sandra Catalina Olaya, Gustavo Quintero, Gabriel Carrasquilla, Carlos Eduardo Pinzón, Catalina López, Juan Camilo Ramírez, Cost-effectiveness of laparoscopic versus open cholecystectomy , Biomedica: Vol. 31 No. 4 (2011)
- Linda Grace Molano Cetina, Presentaciones en cartel , Biomedica: Vol. 31 (2011): Suplemento 3, II Tomo, Memorias XX Congreso Latinoamericano de Parasitología
- Linda Grace Molano Cetina, Presentaciones orales , Biomedica: Vol. 31 (2011): Suplemento 3, II Tomo, Memorias XX Congreso Latinoamericano de Parasitología

Article metrics | |
---|---|
Abstract views | |
Galley vies | |
PDF Views | |
HTML views | |
Other views |